Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implications
Authors:
- Pomila SinghPSPomila Singh
- Malaney O’cOnnellMOMalaney O’cOnnell
- 28 September 2016
- journal article
- editorial
- Published by AME Publishing Company in Stem Cell Investigation
- Vol. 3 (9) , 51
Abstract
Colorectal carcinogenesis is a multi-step process. While ~25% of colorectal cancers (CRCs) arise in patients with a family history (genetic predisposition), ~75% of CRCs are due to age-associated accumulation of epigenetic alterations which can result in the suppression of key tumor suppressor genes leading to mutations and activation of oncogenic pathways. Sporadic colon-carcinogenesis is facilitated by many molecular pathways of genomic instability which include chromosomal instability (CIN), micro-satellite instability (MSI) and CpG island methylator phenotype (CIMP), leading towards loss of homeostasis and onset of neoplastic transformation. The unopposed activation of Wnt/β-catenin pathways, either due to loss of APC function or up-regulation of related stimulatory pathways, results in unopposed hyperproliferation of colonic crypts, considered the single most important risk factor for colon carcinogenesis. Hypermethylation of CpG islands within the promoters of specific genes can potentially inactivate DNA repair genes and/or critical tumor suppressor genes. Recently, CpG methylation of the 5’ promoter of human (h) DCLK1 gene was reported in many human epithelial cancers, including colorectal cancers (CRCs), resulting in the loss of expression of the canonical long isoform of DCLK1 (DCLK1-L) in hCRCs. Instead, a shorter isoform of DCLK1 (DCLK1-S) was discovered to be expressed in hCRCs, from an alternate β promoter of DCLKL1-gene; the clinical and biological implications of these novel findings, in relation to recent publications is discussed.Keywords
This publication has 45 references indexed in Scilit:
- Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasisLaboratory Investigation, 2014
- The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancersInternational Journal of Cancer, 2014
- The recently suggested intestinal cancer stem cell markerDCLK1is an epigenetic biomarker for colorectal cancerEpigenetics, 2014
- Immunolocalization of DCAMKL-1, a putative intestinal stem cell marker, in normal colonic tissuePathology - Research and Practice, 2012
- Insulin-like growth factors are more effective than progastrin in reversing proapoptotic effects of curcumin: critical role of p38MAPKAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Variants in Doublecortin- and Calmodulin Kinase Like 1, a Gene Up-Regulated by BDNF, Are Associated with Memory and General Cognitive AbilitiesPLOS ONE, 2009
- Functional Cross-talk between β-Catenin and NFκB Signaling Pathways in Colonic Crypts of Mice in Response to ProgastrinJournal of Biological Chemistry, 2009
- Doublecortin-like Kinase Controls Neurogenesis by Regulating Mitotic Spindles and M Phase ProgressionNeuron, 2006
- Intestinal expression of mutant and wild‐type progastrin significantly increases colon carcinogenesis in response to azoxymethane in transgenic miceCancer, 2004
- Catalytic and Regulatory Domains of Doublecortin Kinase-1Biochemistry, 2003